Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-03 Conversion | 2024-06-05 7:38 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 141,600 | $0 | 352,607 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 7:38 pm | N/A 2029-09-10 | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 106,200 | $0 | 352,607 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 7:38 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 106,200 | $0.34 | 352,607 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:42 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 213,486 | $0 | 213,486 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:51 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 299,193 | $0 | 299,193 (Direct) | View |
Ownership | 2023-02-02 6:12 pm | N/A 2029-09-10 | Structure Therapeutics Inc. | GPCR | Lin Xichen Chief Scientific Officer | 0 | $0 | 568,000 (Direct) | View |